VolitionRx Limited Management Fee Payable
VolitionRx Limited (VNRX) had Management Fee Payable of $54.39 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ManagementFeePayable · last filed 2026-08-13
- 2026-06-30: Management Fee Payable $54.39K.
- 2026-03-31: Management Fee Payable $68.78K.
- 2025-12-31: Management Fee Payable $80.94K.
- 2025-09-30: Management Fee Payable $115.82K.
| Period end | Management Fee Payable |
|---|---|
| 2026-06-30 | $54.39K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $68.78K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $80.94K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $115.82K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $54.39K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $54.39K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $30.09K 10-K · filed 2026-03-31 |
| 2024-09-30 | $24.85K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $25.07K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $60.25K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $59.63K 10-K · filed 2025-03-31 |
| 2023-09-30 | $59.98K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $73.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $80.14K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $71.12K 10-K · filed 2024-03-25 |
| 2022-09-30 | $71.64K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $74.26K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $97.64K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $71.30K 10-K · filed 2023-03-15 |
| 2021-09-30 | $91.21K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $91.69K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $39.48K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $55.17K 10-K · filed 2022-03-30 |
| 2020-09-30 | $47.67K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $10.50K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $55.66K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $21.98K 10-K · filed 2021-03-22 |
| 2019-09-30 | $48.77K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $45.54K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $5.28K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.20K 10-K · filed 2020-02-20 |
| 2018-09-30 | $57.41K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $26.71K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $20.61K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $35.40K 10-K · filed 2019-03-13 |
| 2017-09-30 | $54.99K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $79.16K 10-Q · filed 2017-08-10 |
| 2017-03-31 | $90.22K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $81.06K 10-K · filed 2018-03-01 |
| 2016-09-30 | $104.15K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $49.76K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $81.27K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $71.89K 10-K · filed 2017-03-10 |
| 2015-09-30 | $94.40K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $88.33K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $176.80K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $146.02K 10-K · filed 2016-03-11 |
| 2014-09-30 | $240.98K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $181.23K 10-Q · filed 2014-08-01 |
| 2014-03-31 | $210.93K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $222.29K 10-K · filed 2015-03-18 |
| 2012-12-31 | $213.51K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |